German Cartel Office Approves Merck KGaA's $10B Bio-Techne Takeover
TECH sits 65% above its 52-week low of $43.195.
Summary
The German Federal Cartel Office has approved Merck KGaA's acquisition of Bio-Techne, clearing a key regulatory hurdle for the $73 per share all-cash deal. The purchase price is about 10 billion euros. This follows the definitive merger agreement announced in June and the preliminary proxy filed last week. With antitrust clearance in Germany secured, the transaction moves closer to completion, though other regulatory approvals and shareholder vote remain. The stock trades near its 52-week high, reflecting the deal premium.
At the time of this announcement, TECH was trading at $71.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $43.20 to $72.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.